Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « case »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
cascade < case < caseloads  Facettes :

List of bibliographic references indexed by case

Number of relevant bibliographic references: 334.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000007 (2021) Natalia Sasoni [Argentine] ; Milton Rodriguez Müller [Argentine] ; Graciela Posse [Argentine] ; Jorge González [Argentine] ; Florencia Leonardelli [Argentine] ; Guillermo Garcia-Effron [Argentine]SARS-CoV-2 and Aspergillus section Fumigati coinfection in an immunocompetent patient treated with corticosteroids.
000023 (2021) Consuelo Luna-Mu Oz [Pérou] ; Giuliana Reyes-Florian [Pérou] ; Martin Seminario-Aliaga [Pérou] ; Angie Stapleton-Herbozo [Pérou] ; Lucy E. Correa-L Pez [Pérou] ; Dante M. Qui Ones-Laveriano [Pérou][Pediatric inflammatory multisystem syndrome associated with COVID-19: A report of 10 cases in a Peruvian hospital].
000029 (2021) Maurizio Koch[2020: Evidence-Based Medicine odyssey. The fall and rise of evidence-based medicine in the year of coronavirus.]
000041 (2021) Keenan M. Mahan [États-Unis] ; Bryan D. Hayes [États-Unis] ; Crystal M. North [États-Unis] ; Justin S. Becker [États-Unis] ; Andrew Z. Fenves [États-Unis] ; Guibenson Hyppolite [États-Unis] ; Sara Khosrowjerdi [États-Unis] ; Daniel Sinden [États-Unis] ; Dana A. Stearns [États-Unis]Utility of Hypertonic Saline and Diazepam in COVID-19-Related Hydroxychloroquine Toxicity.
000051 (2021) Tahani Bin Ali ; Ghaleb Elyamany ; Maha Nojoom ; Mohamed Alfaki ; Hassan Alahmari ; Abdulwahab Alharthi ; Muwaffak Hijazi ; Atif Alsahari ; Fahad Alabbas ; Abdulnasir Al-Otaibi [Arabie saoudite]Unusual presentation of COVID-19 in a child complicated by massive acute pulmonary embolism and lung infarction.
000071 (2021) Matt G. Mckenzie [États-Unis] ; Yeunju Michelle Lee [États-Unis] ; Julin Mathew [États-Unis] ; Megan Anderson [États-Unis] ; Alison T. Vo [États-Unis] ; Samuel Akinyele [États-Unis] ; Malarvizhi Narayanan [États-Unis]Tocilizumab for the Critically Ill With Severe COVID-19: A Community Hospital Case Series.
000078 (2021) Ales Janda [Allemagne] ; Catharina Schuetz [Allemagne] ; Scott Canna [États-Unis] ; Mark Gorelik [États-Unis] ; Maximilian Heeg [Allemagne] ; Kirsten Minden [Allemagne] ; Claas Hinze [Allemagne] ; Ansgar Schulz [Allemagne] ; Klaus-Michael Debatin [Allemagne] ; Christian M. Hedrich [Royaume-Uni] ; Fabian Speth [Allemagne]Therapeutic approaches to pediatric COVID-19: an online survey of pediatric rheumatologists.
000081 (2021) Edoardo Sciatti [Italie] ; Claudio Ceconi [Italie]The strange case of hydroxychloroquine and COVID-19.
000093 (2021) Derek Shyr [États-Unis] ; Yu Shyr [États-Unis]The design and analysis of non-randomized studies: a case study of off-label use of hydroxychloroquine in the COVID-19 pandemic.
000094 (2021) Subham Das [Inde] ; Anu Kunnath Ramachandran [Inde] ; Sumit Raosaheb Birangal [Inde] ; Saleem Akbar [Inde] ; Bahar Ahmed [Inde] ; Alex Joseph [Inde]The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review.
000099 (2021) Zelyn Lee [Canada] ; Craig R. Rayner [États-Unis, Australie] ; Jamie I. Forrest [Canada] ; Jean B. Nachega [Afrique du Sud, États-Unis, Canada] ; Esha Senchaudhuri [Canada] ; Edward J. Mills [Canada]The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19.
000109 (2021) Hailey Olds [États-Unis] ; Jesse Liu [États-Unis] ; Kevin Luk [États-Unis] ; Henry W. Lim [États-Unis] ; David Ozog [États-Unis] ; Pranita V. Rambhatla [États-Unis]Telogen effluvium associated with COVID-19 infection.
000112 (2021) Batool Zamani [Iran] ; Seyed-Masoud Moeini Taba [Iran] ; Mohammad Shayestehpour [Iran]Systemic lupus erythematosus manifestation following COVID-19: a case report.
000122 (2021) Caterina Giannitto [Italie] ; Cristiana Bonifacio [Italie] ; Susanna Esposito [Italie] ; Angela Ammirabile [Italie] ; Giuseppe Mercante [Italie] ; Armando De Virgilio [Italie] ; Giuseppe Spriano [Italie] ; Enrico Heffler [Italie] ; Ludovica Lofino [Italie] ; Letterio Salvatore Politi [Italie] ; Luca Balzarini [Italie]Sudden neck swelling with rash as late manifestation of COVID-19: a case report.
000125 (2021) Andy Sing Ong Tang ; Tze Shin Leong ; Lee Ping Chew ; Hock Hin ChuaSuccessful Non-surgical Treatment of an Acute Calculous Cholecystitis in a Myeloma Patient with Covid-19: Case Report.
000126 (2021) Miles Dale [États-Unis] ; Hiroshi Sogawa [États-Unis] ; Seyed Mohammad Seyedsaadat [États-Unis] ; David C. Wolf [États-Unis] ; Roxana Bodin [États-Unis] ; Bernard Partiula [États-Unis] ; Rajat Nog [États-Unis] ; Rifat Latifi [États-Unis] ; Devon John [États-Unis] ; Gregory Veillette [États-Unis] ; Thomas Diflo [États-Unis] ; Seigo Nishida [États-Unis]Successful Management of COVID-19 Infection in 2 Early Post-Liver Transplant Recipients.
000143 (2021) Artem Minalyan [États-Unis] ; Franklin L. Thelmo [États-Unis] ; Vincent Chan [États-Unis] ; Stephanie Tzarnas [États-Unis] ; Faizan Ahmed [États-Unis]Severe acute respiratory syndrome coronavirus 2-induced acute aortic occlusion: a case report.
000153 (2021) Kavita Manchanda [Inde] ; Jasbir Singh [Inde] ; Ranjeev Bhagat [Inde] ; Ilmjot Kaur Tiwana [Inde] ; Harmanjit Singh [Inde]Safety of pharmacological options for the management of COVID-19 in pregnant women: An Indian perspective.
000179 (2021) Priyamadhaba Behera [Inde] ; Binod Kumar Patro [Inde] ; Arvind Kumar Singh [Inde] ; Pradnya Dilip Chandanshive [Inde] ; Ravikumar S R [Inde] ; Somen Kumar Pradhan [Inde] ; Siva Santosh Kumar Pentapati [Inde] ; Gitanjali Batmanabane [Inde] ; Prasanta Raghab Mohapatra [Inde] ; Biswa Mohan Padhy [Inde] ; Shakti Kumar Bal [Inde] ; Sudipta Ranjan Singh [Inde] ; Rashmi Ranjan Mohanty [Inde]Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study.
000181 (2021) Pravindra Kumar [Inde] ; Ashok Kumar Sah [Inde] ; Greesham Tripathi [Inde] ; Anjali Kashyap [Inde] ; Avantika Tripathi [Inde] ; Rashmi Rao [Inde] ; Prabhu C. Mishra [Inde] ; Koustav Mallick [Inde] ; Amjad Husain [Inde] ; Manoj Kumar Kashyap [Inde]Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
000182 (2021) Philippe Guilpain [France] ; Clément Le Bihan [France] ; Vincent Foulongne [France] ; Patrice Taourel [France] ; Nathalie Pansu [France] ; Alexandre Thibault Jacques Maria [France] ; Boris Jung [France] ; Romaric Larcher [France] ; Kada Klouche [France] ; Vincent Le Moing [France]Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "case" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "case" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    case
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021